News-Detail

Nanotechnology in Cholesterol Research AdobeStock_822311587

A team at Helmholtz Munich and the Technical University of Munich (TUM) has developed a new microscopy technique that can distinguish lipid species in living cells – in particular cholesterol and sphingomyelin – and map them without the need for…

12.07.2023, Neuherberg: Helmholtz Pioneer Campus Opening. Foto: Matthias Balk/Helmholtz Zentrum München

At its most recent plenary session, the Bavarian Academy of Sciences and Humanities (BAdW) elected 13 distinguished scholars as new members. Among them are three researchers from Helmholtz Munich: Prof. Maria-Elena Torres-Padilla, Prof. Fabian Theis,…

EMBO Workshop Biomedical Engineering

Biomedical engineering applies engineering principles to address challenges in medicine and biology. To explore ways of strengthening biomedical engineering as a driver of innovation and growth in Europe, EMBO and the Helmholtz Bioengineering…

Bioengineering

In a joint guest article published in Table.Media, bioengineering expert Vasilis Ntziachristos and deep-tech specialist Francis de Véricourt examine the key levers needed to sustainably advance biomedical innovation in Germany and Europe. The two…

Helmholtz Biomedical Engineering Initiative

The Helmholtz Association is launching a nationwide biomedical engineering initiative to accelerate technology development and transfer activities. Led by its established Health Centers, “Helmholtz Biomedical Engineering” brings together cutting-edge…

Intricate network of red capillaries, a detailed view of microscopic blood vessels conveying vitality

Researchers from Helmholtz Munich and the Technical University of Munich (TUM) have developed “fast-RSOM”, a new imaging technology that can capture detailed images of the smallest blood vessels directly through the skin – without the need for…

A dynamic web of entities and people working together to foster and advance new ideas, technologies, and solutions.

Helmholtz Munich is partnering with Deep Science Ventures (DSV) and SPRIND, Germany’s Federal Agency for Disruptive Innovation, to support the Venture Science Doctorate (VSD) – a novel doctoral program designed to train scientists to build…

Esophageal Cancer

Researchers from Helmholtz Munich, the Technical University of Munich (TUM), and the Medical University of Vienna have developed an advanced imaging technique called "O2E" that allows clinics to detect cancerous lesions in the esophagus with…

A vibrant abstract composition shows interconnected blue dots and lines in a dark environment
KI generated

Researchers at Helmholtz Munich have secured three prestigious Proof of Concept Grants from the European Research Council (ERC). This funding will enable them to advance innovative projects across diverse areas of biomedical research. With a total of…

Multiple Myeloma

Researchers from Helmholtz Munich and the Technical University of Munich have developed a novel method to track cancer treatment responses in individual cells – without the need for dyes or labels. Their mid-infrared optoacoustic microscopy (MiROM)…

Ma_press_fig_v4_QIScope

Researchers at Helmholtz Munich and the Technical University of Munich have developed a new microscope that significantly improves how bioluminescent signals in living cells can be observed. The system, known as QIScope, is built around a highly…

CRISPR gene editing

A research team from Helmholtz Munich and the Technical University of Munich has developed an advanced delivery system that transports gene-editing tools based on the CRISPR/Cas9 gene-editing system into living cells with significantly greater…

HMGU_Icon_Bioengineering

Helmholtz Munich researchers have introduced a new imaging method that exploits light, sound, and temperature-induced material changes. This approach uncovers a novel contrast mechanism in optoacoustic imaging, driven by tiny temperature-based shifts…

Prof. Vasilis Ntziachristos erhält Mitgliedschaftsurkunde der Leopoldina

Since March 2024, Vasilis Ntziachristos has been a member of the German National Academy of Sciences Leopoldina. This esteemed recognition stands as one of the highest honors for scientists and is awarded through a thorough multi-stage selection…

Ali Ertürk with transparent mouse

Imagine a world where the most intricate networks and processes within whole bodies are visible – down to the level of individual molecules. This is what Ali Ertürk’s pioneering research makes possible, opening up new possibilities for medicine and…

Lipid nanoparticles

How can we ensure that life-saving drugs or genetic therapies reach their intended target cells without causing harmful side effects? Researchers at Helmholtz Munich, Ludwig-Maximilians-Universität (LMU) and Technical University Munich (TUM) have…

Microscopic View of Coronavirus

Researchers from Helmholtz Munich and Ludwig-Maximilians-Universität (LMU) have identified a mechanism that may explain the neurological symptoms of Long COVID. The study shows that the SARS-CoV-2 spike protein remains in the brain’s protective…

Prof. Matthias Tschöp

Interview with Prof. Matthias Tschöp about health research and prevention with cutting-edge tools.

HMGU_Icon_Bioengineering

Optoacoustic imaging is transforming biological research by enabling high-resolution imaging at depths beyond traditional optical microscopy. Already applied in clinical settings, this technique now requires more effective optoacoustic labels for use…

Artificial intelligence creation concept. In a certain space, neon lines create a human shape, a connection between man and machine.

The research of Prof. Dr. Vasilis Ntziachristos and his team leads to novel, groundbreaking medical imaging tools. Their non-invasive technologies unveil crucial health and disease details that can empower doctors to identify and address diseases at…

DELiVR mouse brain

Researchers at Helmholtz Munich and the LMU University Hospital Munich introduce DELiVR, offering a new AI-based approach to the complex task of brain cell mapping. The deep learning tool democratizes advanced neuroscience by eliminating the need for…

HMGU_Icon_Bioengineering

Scientists have created a non-invasive technology for measuring glucose levels in blood.

RSOM-Aufnahmen von Haut eines gesunden Probanden (links), eines Patienten mit Diabetes (mitte) und eines Patienten mit Diabetes und Neuropathie (rechts).

Changes in small blood vessels are a common consequence of diabetes development. Researchers at Helmholtz Munich and the Technical University of Munich (TUM) have now developed a method that can be used to measure these microvascular changes in the…

HMGU_Icon_Stem_Cells

Sporadic Parkinson's Disease (sPD) is a progressive neurodegenerative disorder influenced by both genetic and environmental factors. While mitochondrial dysfunction contributes to this condition, its role across disease progression remains unclear.…

DeepMB Press release

Researchers at Helmholtz Munich and the Technical University of Munich have made significant progress in advancing high-resolution optoacoustic imaging for clinical use. Their innovative deep-learning framework, known as DeepMB, holds great promise…

SMCs in human

Alzheimer's, stroke, multiple sclerosis and other neurological diseases cause severe damage due to neuroinflammation mediated by immune cells. Managing this inflammation poses a significant medical challenge because the brain is protected by the…

Whole-body map of the mouse nervous system

Researchers developed a new method called wildDISCO that uses standard antibodies to map the entire body of an animal using fluorescent markers. This revolutionary technique provides detailed 3D maps of structures, shedding new light on complex…

Prof. Dr. Gil Westmeyer

Genetically encoded nano-barcodes

How do the nerve cells in our brain communicate with each other? What processes take place when T cells render cancer cells harmless? Details of the mechanisms at the cellular level remain hidden from view. Now,…

HMGU_Icon_Bioengineering

How can the clinical translation of research findings be accelerated to improve human health? What role does bioengineering play in driving the development of medicine and biology solutions? Matthias Tschöp, CEO at Helmholtz Munich and Alexander von…

HMGU_Icon_Bioengineering

The renal phosphate wasting disease X-linked hypophosphatemia (XLH) is a rare metabolic disorder of the bones associated with severe renal phosphate loss. The first symptoms of the genetic defect appear in childhood and adolescence and can…

IBMI_Slider_03_RSOM_skin

A clinical study confirms the success of a novel technology developed by Helmholtz Munich and the Technical University of Munich (TUM) for the evaluation of the treatment of psoriasis. With the new method, doctors can look deeper into the skin of…

Chain of amino acid or bio molecules called protein - 3d illustration

Biomedical imaging is the window through which we can look into organisms. It allows us to see cells, their behavior and localization that would otherwise be hidden. Tracking very few cells over time without damaging them is a key challenge in health…

Silicon chip

Researchers at Helmholtz Zentrum München and the Technical University of Munich (TUM) have developed the world’s smallest ultrasound detector. It is based on miniaturized photonic circuits on top of a silicon chip. With a size 100 times smaller than…